Spectrum Pharmaceuticals (SPPI)
Add to Watchlists Create an AlertSpectrum Pharmaceuticals Enterprise Value:
439.24M for May 23, 2013Spectrum Pharmaceuticals Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 23, 2013 | 439.24M |
| May 22, 2013 | 439.24M |
| May 21, 2013 | 421.19M |
| May 20, 2013 | 416.44M |
| May 17, 2013 | 421.79M |
| May 16, 2013 | 418.18M |
| May 15, 2013 | 411.57M |
| May 14, 2013 | 416.98M |
| May 13, 2013 | 404.95M |
| May 10, 2013 | 389.31M |
| May 9, 2013 | 377.28M |
| May 8, 2013 | 385.10M |
| May 7, 2013 | 385.10M |
| May 6, 2013 | 381.49M |
| May 3, 2013 | 367.05M |
| May 2, 2013 | 362.84M |
| May 1, 2013 | 359.23M |
| April 30, 2013 | 377.88M |
| April 29, 2013 | 375.47M |
| April 26, 2013 | 380.28M |
| April 25, 2013 | 385.70M |
| April 24, 2013 | 363.44M |
| April 23, 2013 | 361.64M |
| April 22, 2013 | 362.24M |
| April 19, 2013 | 362.84M |
| April 18, 2013 | 353.21M |
| April 17, 2013 | 359.23M |
| April 16, 2013 | 358.03M |
| April 15, 2013 | 353.82M |
| April 12, 2013 | 369.16M |
| April 11, 2013 | 371.86M |
| April 10, 2013 | 363.44M |
| April 9, 2013 | 358.03M |
| April 8, 2013 | 357.42M |
| April 5, 2013 | 363.44M |
| April 4, 2013 | 356.82M |
| April 3, 2013 | 354.42M |
| April 2, 2013 | 365.85M |
| April 1, 2013 | 370.66M |
| March 28, 2013 | 380.89M |
| March 27, 2013 | 380.89M |
| March 26, 2013 | 383.89M |
| March 25, 2013 | 369.46M |
| March 22, 2013 | 356.88M |
| March 21, 2013 | 356.82M |
| March 20, 2013 | 353.82M |
| March 19, 2013 | 368.25M |
| March 18, 2013 | 390.51M |
| March 15, 2013 | 398.93M |
| March 14, 2013 | 401.94M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
SPPI Enterprise Value Benchmarks
| Companies | |
|---|---|
| Elan | 7.224B |
| Agenus | 84.74M |
| Biocryst Pharmaceuticals | 89.43M |
SPPI Enterprise Value Rankings
| Overall |
65th percentile 2741 of 8006 |
| Sector |
64th percentile 244 of 686 in Healthcare |
| Industry |
75th percentile 60 of 248 in Biotechnology |
SPPI Enterprise Value Range, Past 5 Years
| Minimum | -22.23M | Oct 17 2008 |
| Maximum | 826.43M | Jul 9 2012 |
| Average | 282.01M |
